Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I–III: A Systematic Review and Network Meta-Analysis

BACKGROUND: The use of adjuvant therapy for high-risk endometrial cancer patients (HREC) in International Federation of Gynecology and Obstetrics (FIGO) stage I–III remains debatable. This network meta-analysis was conducted to compare and rank adjuvant therapies based on efficacies and toxicities t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ao, Mengyin, Ding, Ting, Tang, Dan, Xi, Mingrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526341/
https://www.ncbi.nlm.nih.gov/pubmed/32950998
http://dx.doi.org/10.12659/MSM.925595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526341/
https://www.ncbi.nlm.nih.gov/pubmed/32950998
http://dx.doi.org/10.12659/MSM.925595

Ejemplares similares